Contact
Please use this form to send email to PR contact of this press release:
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) for Relapsed Multiple Myeloma and Updates Financial Guidance
TO:
Please use this form to send email to PR contact of this press release:
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) for Relapsed Multiple Myeloma and Updates Financial Guidance
TO: